Jilin Aodong Pharmaceutical Group Co Ltd (000623) — Long-term Investment Intensity

Latest as of September 2019: 65.1%

Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a Long-term Investment Intensity of 65.1% as of September 2019. Long-term investments of CN¥16.71 Billion represent 65.1% of total assets of CN¥25.68 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Jilin Aodong Pharmaceutical Group Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

65.1%
LT Investments / Total Assets

Long-term Investments

CN¥16.71 Billion
CNY

Total Assets

CN¥25.68 Billion
CNY

Country

China
SHE

Jilin Aodong Pharmaceutical Group Co Ltd Long-term Investment Intensity (2015–2018)

This chart shows how Jilin Aodong Pharmaceutical Group Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 65.1%, reflecting long-term investments of CN¥16.71 Billion against total assets of CN¥25.68 Billion CNY. For the complete balance sheet picture, see Jilin Aodong Pharmaceutical Group Co Ltd total assets.

Annual Long-term Investment Intensity for Jilin Aodong Pharmaceutical Group Co Ltd (2015–2018)

The table below presents the year-by-year Long-term Investment Intensity for Jilin Aodong Pharmaceutical Group Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read debt load of Jilin Aodong Pharmaceutical Group Co Ltd for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (CNY) Total Assets Change (pp)
2018 65.3% CN¥16.10 Billion CN¥24.66 Billion ▼ -8.9 pp
2017 74.2% CN¥16.21 Billion CN¥21.83 Billion ▲ +3.0 pp
2016 71.2% CN¥14.48 Billion CN¥20.34 Billion ▲ +0.1 pp
2015 71.1% CN¥14.10 Billion CN¥19.83 Billion
pp = percentage points